IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trial
{{output}}
Background: Most biologics for severe asthma target only type 2 immunity. Inhibition of IL-33 signaling has the potential to target type 2 and non-type 2 pathways. ... ...
